🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary aim of this innovative immunotherapeutic study is to determine ...
Status
Active Not Recruiting
Location
ZNA Cadix
Start Date
2012-10
Trial ID
NCT01686334
Treatments Being Tested
This is an open, one-arm study to evaluate the safety and efficacy of mRNA ...
Status
Unknown
Location
Multiple Locations
Start Date
2023-04-20
Trial ID
NCT05761717
Treatments Being Tested
This is a Phase 1 open label study to evaluate the tolerability, safety, im...
Status
Unknown
Location
Pindara Private Hospital
Start Date
2022-03-18
Trial ID
NCT05198752
Treatments Being Tested
This is a Phase I, single-arm, open-label, prospective, non-randomized, sin...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-31
Trial ID
NCT07724106
Treatments Being Tested
This is an open-label, multicenter, 2-arm study to evaluate the safety and ...
Status
Completed
Location
Research Facility
Start Date
2017-12-20
Trial ID
NCT03164772
Treatments Being Tested
Although immune checkpoint inhibitors (ICIs) have substantially extended su...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09
Trial ID
NCT07597070
Treatments Being Tested
This is a first-in-human, open label phase I study in ovarian cancer patien...
Status
Terminated
Location
UMCG
Start Date
2019-11-25
Trial ID
NCT04163094
Treatments Being Tested
The Investigators have demonstrated in preclinical studies that RNA liposom...
Status
Active Not Recruiting
Location
UF Health
Start Date
2025-03-12
Trial ID
NCT05660408
Treatments Being Tested
Treatment of a patient with recurrent osteosarcoma with personalized pp65/t...
Status
No Longer Available
Location
University of Florida Health
Start Date
TBD
Trial ID
NCT07560709
Treatments Being Tested
This study will determine the safety and tolerability and establish a preli...
Status
Terminated
Location
Banner MD Anderson Cancer Center ( Site 1008)
Start Date
2019-06-26
Trial ID
NCT03948763
Treatments Being Tested